Procter & Gamble Investing Cash Flow decreased by 44.4% to -$1.54B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 38.5%, from -$1.11B to -$1.54B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 7.8% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$791.00M | -$1.01B | -$316.00M | -$2.42B | -$682.00M | -$832.00M | -$1.39B | -$478.00M | -$798.00M | -$1.22B | -$807.00M | -$957.00M | -$518.00M | -$1.11B | -$1.66B | $0.00 | -$1.06B | -$1.54B |
| QoQ Change | — | -27.2% | +68.6% | -665.8% | +71.8% | -22.0% | -67.3% | +65.7% | -66.9% | -53.1% | +34.0% | -18.6% | +45.9% | -113.9% | -49.4% | +100.0% | — | -44.4% |
| YoY Change | — | — | — | — | +13.8% | +17.3% | -340.5% | +80.2% | -17.0% | -46.9% | +42.0% | -100.2% | +35.1% | +9.3% | -105.1% | +100.0% | -105.2% | -38.5% |